INS and Insulin resistance: Combination treatment with the two drugs additively reversed the changes in plasma levels of adipocytokines, suggesting that ipragliflozin and pioglitazone attenuate insulin resistance, at least in part, via different mechanisms such as direct anti‐hyperglycemic effects and insulin‐sensitizing activity in the liver, adipose, and muscle tissues.